Impact factor: 0.567, Impact factor a 5 anni: 0.49
Url: Non disponibile.
Parole chiave: Advances In Imaging, Colorectal Cancer, Liver Metastases,
*** IBB - CNR *** Pier Paolo Mainenti, Laura Pizzuti, IBB CNR, 80145 Naples, Italy., 1Pier Paolo Mainenti, Laura Pizzuti, IBB CNR, 80145 Naples, Italy.
Colorectal cancer is one of the few malignant tumors in which synchronous or metachronous liver metastases [colorectal liver metastases (CRLMs)] may be treated with surgery. It has been demonstrated that resection of CRLMs improves the long-term prognosis. On the other hand, patients with un-resectable CRLMs may benefit from chemotherapy alone or in addition to liver-directed therapies. The choice of the most appropriate therapeutic management of CRLMs depends mostly on the diagnostic imaging. Nowadays, multiple non-invasive imaging modalities are available and those have a pivotal role in the workup of patients with CRLMs. Although extensive research has been performed with regards to the diagnostic performance of ultrasonography, computed tomography, positron emission tomography and magnetic resonance for the detection of CRLMs, the optimal imaging strategies for staging and follow up are still to be established. This largely due to the progressive technological and pharmacological advances which are constantly improving the accuracy of each imaging modality. This review describes the non-invasive imaging approaches of CRLMs reporting the technical features, the clinical indications, the advantages and the potential limitations of each modality, as well as including some information on the development of new imaging modalities, the role of new contrast media and the feasibility of using parametric image analysis as diagnostic marker of presence of CRLMs.
23 Records (18 escludendo Abstract e Conferenze). Impact factor totale: 78.56 (57.314 escludendo Abstract e Conferenze). Impact factor a 5 anni totale: 71.485 (49.157 escludendo Abstract e Conferenze).